Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Alaunos Therapeutics, Inc. Transaction History

Mitsubishi Ufj Kokusai Asset Management Co., Ltd.

$81.3 Billion
Q2 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$1.09 - $1.89 $105,859 - $183,554	-97,119 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$2.63 - $3.67 $98,233 - $137,078	-37,351 Reduced 27.78%	97,119 $256,000
Q1 2021 May 06, 2021	BUY	$2.82 - $5.6 $121,846 - $241,964	43,208 Added 47.35%	134,470 $484,000
Q4 2020 Feb 09, 2021	BUY	$2.09 - $3.09 $52,091 - $77,015	24,924 Added 37.57%	91,262 $230,000
Q3 2020 Nov 10, 2020	SELL	$2.39 - $3.43 $6,264 - $8,990	-2,621 Reduced 3.8%	66,338 $167,000
Q2 2020 Aug 06, 2020	BUY	$2.2 - $3.71 $68,175 - $114,969	30,989 Added 81.61%	68,959 $226,000
Q1 2020 May 11, 2020	BUY	$1.9 - $4.98 $13,275 - $34,795	6,987 Added 22.55%	37,970 $93,000
Q4 2019 Feb 05, 2020	SELL	$3.95 - $5.35 $11,040 - $14,953	-2,795 Reduced 8.27%	30,983 $139,000
Q3 2019 Nov 12, 2019	BUY	$4.13 - $6.94 $27,324 - $45,915	6,616 Added 24.36%	33,778 $145,000
Q2 2019 Aug 08, 2019	SELL	$3.98 - $6.2 $102,321 - $159,395	-25,709 Reduced 48.63%	27,162 $158,000
Q1 2019 Apr 26, 2019	BUY	$2.0 - $4.4 $11,604 - $25,528	5,802 Added 12.33%	52,871 $204,000
Q4 2018 Feb 08, 2019	BUY	$1.61 - $3.62 $27,579 - $62,010	17,130 Added 57.22%	47,069 $101,000
Q3 2018 Nov 13, 2018	BUY	$2.26 - $3.27 $67,662 - $97,900	29,939 New	29,939 $96,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.

Account